A phase 2 randomized trial of a new minocycline foam for the treatment of moderate-to-severe acne vulgaris
A randomized, evaluator-blinded, controlled study of efficacy and safety of a small particle hyaluronic acid plus lidocaine for lip augmentation
Access of efinaconazole topical solution, 10%, to the infection site by spreading through the subungual space
Adapalene-benzoyl peroxide gel is efficacious and safe in adult female acne
An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 3.75% for the once-daily treatment of moderate-to-severe acne vulgaris: assessment of efficacy in 498 patients
An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 3.75% for the once-daily treatment of moderate-to-severe acne vulgaris: assessment of safety in 498 patients
An in vitro study demonstrating nail penetration of tavaborole topical solution, 5% through multiple layers of nail polish
An innovative aerosol foam formulation of calcipotriene 0.005% plus betamethasone dipropionate 0.064% is more efficacious than Cal and BD foam alone in treating psoriasis vulgaris: a randomized, double-blind, multicenter, three-arm, Phase 2 study
AN2728, a new boron-based topical antiinflammatory agent, inhibits phosphodiesterase 4 (PDE4)
Antipsoriatic effect of an innovative aerosol foam formulation of the fixed combination calcipotriene plus betamethasone dipropionate in patients with psoriasis, using a modified psoriasis plaque test
Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate-to-severe psoriasis: results of a phase 3, randomized, controlled trial (ESTEEM 2)
Apremilast in moderate-to-severe plaque psoriasis: 32-week results in patients with nail, scalp, and palmoplantar involvement (ESTEEM 2)
Brimonidine gel 0.33% improves patient-reported outcomes in severe facial erythema of rosacea
Coblation debridement of chronic venous ulcers: a pilot clinical case series
Comparative efficacy and safety of ivermectin cream 1% and metronidazole cream 0.75% in the treatment of papulopustular rosacea
Correction of midface volume deficits and contour deficiencies using a large gel particle hyaluronic acid filler
Effect of calcipotriene plus betamethasone dipropionate topical suspension on the hypothalamic-pituitary-adrenal (HPA) axis and calcium metabolism in adolescents with extensive scalp psoriasis: an open, noncontrolled, 8-week trial
Efficacy and safety of adapalene 0.3%/benzoyl peroxide 2.5% topical gel in moderate and severe acne vulgaris
Efficacy of adlimumab compared with MTX or placebo by baseline BMI in a randomized controlled trial
Efficacy of a multimodal brightening regimen in Asian subjects with moderate-to-severe facial hyperpigmentation
Efficacy, safety, and subject satisfaction of a complete regimen to cleanse, medicate, moisturize, and photoprotect the skin of subjects with mild-to-moderate acne vulgaris
Efinaconazole topical solution, 10%: efficacy in onychomycosis patients with coexisting tinea pedis
Efinaconazole topical solution, 10%: the benefits of treating onychomycosis early
Efinaconazole topical solution, 10% for the treatment of mild and moderate toenail onychomycosis
Efinaconazole topical solution, 10% for the treatment of mild and moderate toenail onychomycosis: gender as a clinically relevant outcome variable
Efinaconazole topical, 10% for the treatment of toenail onychomycosis in patients with diabetes
Enhancing the transungual delivery of efinaconazole through a unique formulation approach
Evaluation of the appearance of nail polish following daily treatment of ex vivo human fingernails with topical solutions of tavaborole or efinaconazole
Fixed combination aerosol foam calcipotriene 0.005% (Cal) plus betamethasone dipropionate 0.064% (BD) exhibits no clinically relevant impact on the HPA axis and calcium homeostasis in patients with extensive psoriasis vulgaris: a multicenter, single-arm, open label, 4-week MUSE study
Improvement of signs of xerosis and pruritus in elderly subjects using a skincare regimen formulated with filaggrin and ceramide technology
Ingenol mebutate gel, 0.05%, for patients with actinic keratosis of the scalp
Ingenol mebutate 0.015% gel follow-up use for multiple actinic keratoses on face and scalp: a randomized 12-month phase 3 study
Innovation in papulopustular rosacea treatment: efficacy and safety of ivermectin 1% cream
Long-term safety of ivermectin 1% cream vs azelaic acid 15% gel in treating inflammatory lesions of rosacea
Malignancies in the psoriasis longitudinal assessment and registry (PSOLAR) study: current status observations
PASI by body region in a randomized, placebocontrolled trial of adalimumab
Penetration of (14C)-efinaconazole topical solution, does not appear to be influenced by nail polish
Persistence of biologic therapy in the psoriasis longitudinal assessment and registry (PSOLAR)
Pilot study: efficacy and tolerability of a nondrying topical lotion combined with chemical peels in adult female subjects with moderate facial acne and postinflammatory lesions
Punch-grafting for treatment of chronic leg and foot ulcers: a retrospective chart study
Safety and efficacy of calcipotriene plus betamethasone dipropionate topical suspension in adolescents with scalp psosriasis: an open, noncontrolled, 8-week trial
Superior efficacy of the fixed combination calcipotriene plus betamethasone dipropionate in an innovative aerosol foam versus ointment, in patients with psoriasis vulgaris
The efficacy and tolerability of a fixed combination clindamycin (1.2%) and benzoyl peroxide (3.75%) aqueous gel in patients with facial acne vulgaris: gender as a clinically relevant outcome variable
The efficacy and tolerability of a fixed combination of clindamycin (1.2%) and benzoyl peroxide (3.75%) aqueous gel in adult females with facial acne vulgaris
Treatment of onychomycosis with efinaconazole topical solution, 10% and quality of life